Financials: Bristol-Myers Squibb Company (BMY)
BMY on New York Consolidated
24.25USD
9 Feb 2010
24.25USD
9 Feb 2010
Price Change (% chg)
$0.29 (+1.21%)
$0.29 (+1.21%)
Prev Close
$24.25
$24.25
Open
--
--
Day's High
$24.30
$24.30
Day's Low
$23.76
$23.76
Volume
9,905,306
9,905,306
Avg. Vol
14,284,917
14,284,917
52-wk High
$26.62
$26.62
52-wk Low
$17.23
$17.23
Revenue
Earnings Per Share
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-10 | 11 | 4,713.01 | 4,900.00 | 4,550.00 | -- |
| Quarter Ending Jun-10 | 11 | 4,945.43 | 5,000.00 | 4,873.00 | -- |
| Year Ending Dec-10 | 15 | 19,967.50 | 20,325.00 | 19,602.90 | 23,265.30 |
| Year Ending Dec-11 | 14 | 20,995.00 | 21,680.00 | 19,955.00 | 24,578.30 |
| EARNINGS (per share) | |||||
| Quarter Ending Mar-10 | 13 | 0.53 | 0.57 | 0.49 | -- |
| Quarter Ending Jun-10 | 11 | 0.57 | 0.59 | 0.54 | -- |
| Year Ending Dec-10 | 17 | 2.21 | 2.30 | 2.14 | 2.23 |
| Year Ending Dec-11 | 16 | 2.45 | 2.62 | 2.15 | 2.53 |
| LT Growth Rate (%) | 7 | 4.96 | 12.50 | -2.00 | 9.59 |
Sales and Earnings Figures in U.S. Dollars (USD)
Valuation Ratios
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| P/E Ratio (TTM) | 14.95 | 6.43 | 3.76 | 14.59 |
| P/E High - Last 5 Yrs. | NA | 0.87 | 1.59 | 16.18 |
| P/E Low - Last 5 Yrs. | NA | 0.39 | 0.55 | 4.36 |
| Beta | 0.69 | 0.71 | 0.65 | 1.33 |
| Price to Sales (TTM) | 2.52 | 1.42 | 1.22 | 2.01 |
| Price to Book (MRQ) | -- | 2.16 | 1.99 | 2.58 |
| Price to Tangible Book (MRQ) | -- | 2.25 | 3.19 | 5.66 |
| Price to Cash Flow (TTM) | -- | 4.22 | 2.07 | 7.12 |
| Price to Free Cash Flow (TTM) | -- | 19.66 | 24.92 | 12.79 |
| % Owned Institutions | -- | -- | -- | -- |
Dividends
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Dividend Yield | 5.34 | 0.89 | 0.29 | 1.71 |
| Dividend Yield - 5 Year Avg. | 4.73 | 1.57 | 1.60 | 2.35 |
| Dividend 5 Year Growth Rate | 2.22 | 9.24 | 15.63 | -5.31 |
| Payout Ratio(TTM) | -- | 11.19 | 4.46 | 24.71 |
Growth Rates
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 10.81 | 15.76 | 6.84 | 10.73 |
| Sales (TTM) vs TTM 1 Yr. Ago | 6.17 | 3.90 | 1.90 | -4.74 |
| Sales - 5 Yr. Growth Rate | -0.60 | 6.42 | 8.05 | 7.42 |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -27.61 | 58.37 | 142.38 | 98.28 |
| EPS (TTM) vs TTM 1 Yr. Ago | 18.84 | -- | -- | -- |
| EPS - 5 Yr. Growth Rate | 5.79 | 6.61 | 5.61 | 8.85 |
| Capital Spending - 5 Yr. Growth Rate | -- | 4.77 | 6.95 | 5.91 |
Financial Strength
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.39 | 2.57 | 0.81 |
| Current Ratio (MRQ) | -- | 3.00 | 3.05 | 0.95 |
| LT Debt to Equity (MRQ) | -- | 21.44 | 25.13 | 127.01 |
| Total Debt to Equity (MRQ) | -- | 25.97 | 32.96 | 179.52 |
| Interest Coverage (TTM) | -- | 6.95 | 3.69 | 11.83 |
Profitability Ratios
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Gross Margin (TTM) | 72.67 | 31.44 | 12.78 | 31.64 |
| Gross Margin - 5 Yr. Avg. | 69.30 | 47.54 | 56.69 | 29.11 |
| EBITD Margin (TTM) | -- | -- | -- | -- |
| EBITD - 5 Yr. Avg | -- | 17.37 | 16.23 | 15.13 |
| Operating Margin (TTM) | 29.79 | 10.65 | -4.90 | -- |
| Operating Margin - 5 Yr. Avg. | 22.29 | 15.22 | 12.24 | 17.30 |
| Pre-Tax Margin (TTM) | 29.79 | 11.05 | -4.88 | 12.47 |
| Pre-Tax Margin - 5 Yr. Avg. | 22.29 | 15.79 | 14.23 | 16.97 |
| Net Profit Margin (TTM) | 23.50 | 9.00 | -5.71 | 9.80 |
| Net Profit Margin - 5 Yr. Avg. | 17.53 | 11.97 | 7.73 | 12.33 |
| Effective Tax Rate (TTM) | 21.10 | 7.14 | 3.58 | 14.83 |
| Effecitve Tax Rate - 5 Yr. Avg. | 21.33 | 17.07 | 34.40 | 26.46 |
Efficiency
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 4,863,234 | 1,282,917 | 299,091 |
| Net Income/Employee (TTM) | -- | 887,247 | 213,959 | 26,863 |
| Receivable Turnover (TTM) | -- | 1.70 | 0.89 | 8.07 |
| Inventory Turnover (TTM) | -- | 0.73 | 0.64 | 5.03 |
| Asset Turnover (TTM) | -- | 0.23 | 0.12 | 0.44 |
Management Effectiveness
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Return on Assets (TTM) | -- | 4.75 | 1.78 | 4.25 |
| Return on Assets - 5 Yr. Avg. | -- | 7.47 | 6.74 | 4.83 |
| Return on Investment (TTM) | -- | 5.95 | 2.30 | 5.67 |
| Return on Investment - 5 Yr. Avg. | -- | 9.43 | 8.69 | 6.33 |
| Return on Equity (TTM) | -- | 8.98 | 2.82 | 12.56 |
| Return on Equity - 5 Yr. Avg. | -- | 11.96 | 10.04 | 12.84 |
| 1 Year | 3 Years | 5 Years | |
|---|---|---|---|
| Sales % | 6.17 | 5.08 | -0.60 |
| EPS % | 19.10 | 37.36 | 5.79 |
| Dividend % | 0.81 | 3.73 | 2.22 |
Note: Units in Millions of US Dollars
Performance for Bristol-Myers Squibb Company
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -4.47 | 3.69 | 94 | 62 |
| 13 Week | 3.95 | 7.52 | 99 | 61 |
| 26 Week | 9.51 | 4.36 | 99 | 66 |
| 52 Week | 3.86 | -14.63 | 53 | 18 |
| YTD | -5.11 | 0.13 | 58 | 46 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 84.57% |
| # of Holders: | 1,366 |
| Total Shares Held: | 1,447,569,342 |
| 3 Mo. Net Change: | 42,964,798 |
| # New Positions: | 31 |
| # Closed Positions: | 24 |
| # Increased Positions: | 168 |
| # Reduced Positions: | 270 |
| # Net Buyers: | -102 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.





